Home>>Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.

Search

About

Authors:
Address: Departments of Pathology, Osaka University Graduate School of Medicine, Yamada-oka, Suita, Japan.
Journal:


Publication:


abstract

Tumor cells with tumorigenic potential might be limited to a small population of cells, called cancer-initiating cells (CICs). CICs efficiently form colonies in vitro, yield both CIC and non-CIC populations, maintain Reactive oxygen species (ROS) at low levels, show high aldehyde dehydrogenase (ALDH) activity, and are mostly in a quiescent state of the cell cycle. CICs of Hodgkin lymphoma (HL) are small in size, with low levels of ROS. The relationship between ROS level and ALDH activity in CICs was examined in HL cell lines. ROS-low and ALDH-high populations formed colonies in semi-solid cultures more efficiently than ROS-high and ALDH-low populations. ALDH-high populations yielded both ALDH-low and -high populations, whereas ALDH-low populations rarely yielded an ALDH-high population. The number of cells in a quiescent state was significantly greater in ROS-low than in ROS-high cells, whereas that of ALDH-high and ALDH-low cells was comparable to each other. These findings show that ALDH-high and ROS-low cells share CIC-like potential, but they differ in their cell cycle status, suggesting that CICs are comprised of cells with heterogeneous characteristics.



Related Articles
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
PLoS One. 2011
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE. PLoS One. 2011; 6(6):e20636. Epub 2011 Jun 13.
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Clin Cancer Res. 2011
Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C, Wang Y, Lozano-Leon A, Ferris RL, Silver S, Szczepanski MJ, Brand RE, Ferrone CR, Whiteside TL, Ferrone S, et al. Clin Cancer Res. 2011 Oct 1; 17(19):6174-84. Epub 2011 Aug 19.
Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.
Am J Pathol. 2010
Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.
Ikeda J, Mamat S, Tian T, Wang Y, Rahadiani N, Aozasa K, Morii E. Am J Pathol. 2010 Dec; 177(6):3081-8. Epub 2010 Oct 15.
Review Aldehyde dehydrogenases and their role in carcinogenesis.
Crit Rev Biochem Mol Biol. 1992
Review Aldehyde dehydrogenases and their role in carcinogenesis.
Lindahl R. Crit Rev Biochem Mol Biol. 1992; 27(4-5):283-335.
Review Aldehyde dehydrogenase as a marker for stem cells.
Curr Stem Cell Res Ther. 2008
Review Aldehyde dehydrogenase as a marker for stem cells.
Moreb JS. Curr Stem Cell Res Ther. 2008 Dec; 3(4):237-46.